Cercano Management’s AbbVie ABBV Stock Holding History

Cercano Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$450K	Hold	1,789	–	–	0.06%	86
2026 Q1	$389K	Hold	1,789	–	–	0.02%	105
2025 Q4	$409K	Hold	1,789	–	–	0.02%	105
2025 Q3	$414K	Hold	1,789	–	–	0.02%	114
2025 Q2	$332K	Hold	1,789	–	–	0.01%	123
2025 Q1	$375K	Sell	1,789 -96,583	-98%	-$18.8M	0.01%	114
2024 Q4	$17.5M	Buy	98,372 +96,583	+5,399%	+$17.8M	0.44%	46
2024 Q3	$353K	Buy	+1,789	New	+$334K	0.01%	124
2023 Q1	–	Sell	-2,800	Closed	-$453K	–	115
2022 Q4	$453K	Buy	+2,800	New	+$429K	0.02%	86

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cercano Management's ABBV Position: Q2 2026 in Review

Cercano Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,789 shares worth $450K. The position accounts for 0.06% of the portfolio, ranked #86.

Cercano Management first reported a position in ABBV in Q4 2022 and has held it in 9 quarters since. The position peaked at $17.5M in Q4 2024. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cercano Management held 1,789 shares of AbbVie worth $450K as of Q2 2026.
Cercano Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.06% of Cercano Management's portfolio in Q2 2026, its #86 holding.
Cercano Management first reported a position in AbbVie in Q4 2022 and has held it in 9 quarters since.
Cercano Management's AbbVie position peaked at $17.5M in Q4 2024.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cercano Management's 13F filing for Q2 2026, filed 13 Aug 2026.